ESMO Virtual Plenary with AACR Expert Commentary: May 2024
- Start date
- 09 May 2024
- End date
- 10 May 2024
- Live on
- 09 May 2024 at 18:00 CEST
Fuzuloparib with or without apatinib in HER2- metastatic breast cancer (mBC) patients (pts) with germline BRCA1/2 mutations (gBRCA1/2m): A randomized phase III trial
Thursday, 9 May 2024 |
Friday, 10 May 2024 |
---|---|
18:00-19:00 CEST |
12:00-13:10 CEST |
Programme
Welcome and introduction, Scientific background and context Fuzuloparib with or without apatinib in HER2- metastatic breast cancer (mBC) patients (pts) with germline BRCA1/2 mutations (gBRCA1/2m): A randomized phase III trial Critical analysis and perspectives Discussion and Q&A (i) |
Programme
Virtual Plenary Expert Insights: Webcast of 9 May presentations, Discussion and Q&A (ii) Chair: Rebecca Dent, NCCS – National Cancer Centre Singapore, Singapore Huiping Li, Peking University Cancer Hospital and Institute, Beijing, China Evandro de Azambuja, Institute Jules Bordet, Brussels, Belgium Smruti Koppikar, Bombay Hospital and Medical Research Center, Mumbai, India Mastura MD Yusof, Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia |
A randomized study of 6 vs 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse
Thursday, 9 May 2024 |
Friday, 10 May 2024 |
---|---|
19:15-20:15 CEST |
13:25-14:35 CEST |
Programme
Welcome and introduction, Scientific background and context A randomized study of 6 vs 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse Critical analysis and perspectives AACR Expert Commentary Discussion and Q&A (i) |
Programme
Virtual Plenary Expert Insights: Webcast of 9 May presentations, Discussion and Q&A (ii) Chair: Herbert Loong, The Chinese University of Hong Kong - Prince of Wales Hospital, Hong Kong SAR, China Jean-Yves Blay, Centre Léon Bérard, Lyon, France Hans Gelderblom, LUMC-Leiden University Medical Center, Leiden, the Netherlands Tom Wei-Wu Chen, NTU - National Taiwan University - College of Medicine, Taipei City, Taiwan Myo Myint Maw, YGH – Yangon General Hospital, Yangon, Myanmar Virote Sriuranpong, King Chulalongkorn Memorial Hospital - Thai Red Cross Society, Bangkok, Thailand |